Howard J G, Vicari G, Courtenay B M
Immunology. 1975 Oct;29(4):585-97.
Native dextran B512 is a near-linear glucose polymer with 96 per cent alpha1--6 and 4 per cent alpha1--3 linkages and a molecular weight (mol. wt) of 8 X 10(7). Sheep RBC sensitized with its O-stearoyl derivative (prepared by a modified method) have been used satisfactorily in direct PFC assays. B512 immunizes BALB/c mice optimally with doses of 1--10 mug and produces B-cell tolerance with 1 mg upwards. The specificity of the response determined by PFC inhibition analysis, is directed towards an alpha1--6-linked epitope. High dose tolerance is not preceded by immunity and is stable on cell transfer to irradiated recipients in which responsiveness becomes perceptible after 4--6 weeks. Progressive depolymerization of this polysaccharide reduces immunogenicity and tolerogenicity, both of which are extinguished when the mol. wt falls to 2 X 10(4). Optimal immunization with B512 is succeeded by partial tolerance (previously characterized by analogous levan experiments as a B-cell exhaustion process). The tolerance threshold dose of B512 is reduced 1000-fold during immunosuppression with cyclophosphamide. PFC inhibition studies supported the contention that tolerogenicity of polysaccharides is influenced by their overall binding capacities. A direct relationship between inhibitory and tolerogenic activities was found both with B512 fractions of varying mol. wt and with heterologous dextrans. The similarities between B512 and levan argue against the association of a highly branched structure with greater tolerogenicity. The effect of reducing the percentage of alpha1--6 linkages in dextrans suggests, however, that epitope density probably plays a contributory role in determining the outcome of interaction between polysaccharides and B cells.
天然右旋糖酐B512是一种近线性的葡萄糖聚合物,具有96%的α1-6和4%的α1-3键,分子量为8×10⁷。用其O-硬脂酰衍生物(通过改良方法制备)致敏的绵羊红细胞已成功用于直接PFC测定。B512以1-10微克的剂量能最佳地免疫BALB/c小鼠,1毫克及以上剂量则会产生B细胞耐受性。通过PFC抑制分析确定的反应特异性针对α1-6连接的表位。高剂量耐受性之前并无免疫反应,且在细胞转移至受照射受体后稳定,受体在4-6周后恢复反应性。这种多糖的逐步解聚会降低免疫原性和耐受性,当分子量降至2×10⁴时,两者均消失。用B512进行最佳免疫后会出现部分耐受性(之前在类似的果聚糖实验中被描述为B细胞耗竭过程)。在用环磷酰胺进行免疫抑制期间,B512的耐受性阈值剂量降低了1000倍。PFC抑制研究支持了多糖的耐受性受其总体结合能力影响的观点。在不同分子量的B512组分以及异源右旋糖酐中均发现抑制活性和耐受性活性之间存在直接关系。B512和果聚糖之间的相似性表明,高度分支的结构与更高的耐受性并无关联。然而,降低右旋糖酐中α1-6键百分比的效果表明,表位密度可能在决定多糖与B细胞相互作用的结果中起作用。